Citi analyst Filippo Falorni lowered the firm’s price target on Clorox (CLX) to $135 from $140 and keeps a Neutral rating on the shares. The firm adjusted price targets in the beverages, household and personal care group as part of a Q2 preview. It sees a slightly improved fundamentals across the sector heading into the reports relative to Q1.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLX:
- Clorox price target lowered to $135 from $142 at Wells Fargo
- Musk to launch new political party, Trump threatens BRICS tariff: Morning Buzz
- Clorox using generative AI for ad creation, WSJ reports
- Clorox price target lowered to $145 from $167 at Jefferies
- Clorox Amends Bylaws to Enhance Shareholder Engagement